沉默HIF-1α调控SLC7A11对喉癌细胞生长的实验研究

doi:10.3969/j.issn.1006-6233.2024.10.025

Abstract
Figure/Table
References
Related Citation (2)

Download: PDF (1827 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the specific effect of silencing HIF-1α on SLC7A11 in laryngeal cancer, and to find new tumor markers and potential therapeutic targets for clinical diagnosis of laryngeal cancer. Methods: UMSCC5 laryngeal cancer cells were cultured and transfected with HIF-1α-siRNA. Western blot was used to screen the best transfection efficiency. CCK-8 was used to detect the proliferation activity of the transfected cells. Flow cytometry was used to detect the apoptosis of each group. Transwell method was used to detect cell invasion and migration. Western blot was used to detect the expression of HIF-1α and SLC7A11. Results: The expression of HIF-1α was successfully silenced, and the transfection efficiency of HIF-1α-siRNA1 group was the highest and the most stable ( P<0.05 ). Silencing HIF-1α can significantly inhibit the proliferation of human laryngeal carcinoma UMSCC5 cells ( P<0.05 ), promote apoptosis ( P<0.05 ), and inhibit the invasion and migration of laryngeal carcinoma cells ( P<0.05 ). Silencing HIF-1α could significantly down-regulate the expression of SLC7A11 protein ( P<0.05 ). Conclusion: Silencing HIF-1α can inhibit the proliferation, invasion, migration and apoptosis of human laryngeal carcinoma UMSCC5 cells, and inhibit the expression of SLC7A11. It provides new ideas and theoretical basis for clinical molecular targeted therapy of laryngeal cancer based on HIF-1α in the future.

Key words： HIF-1α SLC7A11 LSCC

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2024.10.025 OR http://www.hbyxzzs.cn/EN/Y2024/V30/I10/1718

[1] Cossu AM, Mosca L, Zappavigna S, et al. Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours[J].Int Mol Sci,2019,20(14):3444.
[2] Takeuchi T, Kawasaki H, Luce A, et al. Insight toward the microRNA profiling of laryngeal cancers: biological role and clinical impact[J].Int Mol Sci, 2020,21(10):3693.
[3] 谢晓丹,韩瑞,卜倩倩,等.靶向沉默CXCL5对喉鳞状细胞癌AMC-HN-8细胞生物学功能的影响及其调控分析[J].中国生物制品学杂志,2024,37(1):17-25.
[4] Munoz-Galvan S, Verdugo-Sivianes EM, Santos-Pereira JM,, et al.Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors[J].Exp Clin Cancer Res,2024,43(1):57.
[5] Eberly HW, Sciscent BY, Lorenz FJ, et al. Current and emerging diagnostic, prognostic, and predictive biomarkers in head and neck cancer[J].Biomedicines,2024,12(2):415.
[6] Swartz JE, Pothen AJ, Stegeman I, et al. Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review[J].Cancer Med,2015,4(7):1101-1116.
[7] Dyachenko EI, Bel'skaya LV. The role of amino acids in non-enzymatic antioxidant mechanisms in cancer: a review[J].Metabolites,2023,14(1):28.
[8] Luomala L, Mattila K, Vainio P, et al. Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma[J].Cancer Med,2024,13(3):6998.
[9] Musleh Ud Din S, Streit SG, Huynh BT, et al. Therapeutic targeting of hypoxia-inducible factors in cancer[J].Int Mol Sci,2024,25(4):2060.
[10] 赵艳,金鑫,李楠,等.ALDH1、HIF-1α和VEGF在喉鳞状细胞癌中的表达及意义[J].四川大学学报(医学版),2017,48(3):399-404.
[11] Van den Bovenkamp K, van der Vegt B, Halmos GB, et al. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer[J].Eur Arch Otorhinolaryngol,2023,280(8):3801-3809.
[12] Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy[J].Protein Cell,2021,12(8):599-620.
[13] Lin W, Wang C, Liu G, et al. SLC7A11/xCT in cancer: biological functions and therapeutic implications[J]. Am Cancer Res,2020,10(10):3106-3126.
[14] Ma Z, Zhang H, Lian M, et al. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma[J].Oncol Rep,2017,38(5):3019-3029.
[15] Zhang J, Xu J, Dong Y, et al. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression[J].Biosci Rep,2018,38(6):741.
[16] Yang Z, Su W, Wei X, et al. HIF-1α drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1[J].Cell Rep,2023,42(8):112945.
[17] Yan Y, Teng H, Hang Q, et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells[J].Nat Commun,2023,14(1):3673.